Shares of Tilray Inc (NASDAQ:TLRY – Get Free Report) shot up 1.1% during mid-day trading on Thursday . The stock traded as high as $1.84 and last traded at $1.82. 3,926,683 shares traded hands during trading, a decline of 84% from the average session volume of 25,011,896 shares. The stock had previously closed at $1.80.
Tilray Trading Down 3.4 %
The company has a 50 day moving average price of $1.81 and a 200 day moving average price of $1.87. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. The firm has a market cap of $1.45 billion, a price-to-earnings ratio of -3.91 and a beta of 2.13.
Tilray (NASDAQ:TLRY – Get Free Report) last announced its earnings results on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The company’s quarterly revenue was up 24.8% compared to the same quarter last year. During the same period last year, the business earned ($0.15) EPS. On average, research analysts expect that Tilray Inc will post -0.16 earnings per share for the current year.
Institutional Trading of Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Further Reading
- Five stocks we like better than Tilray
- What is the FTSE 100 index?
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- How is Compound Interest Calculated?
- MarketBeat Week in Review – 9/16 – 9/20
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.